MedPath

Influence of gender on the effect-site concentration of remifentanil for the the conventional laryngeal mask airway insertion during target-controlled infusion of propofol

Not Applicable
Completed
Conditions
Not Applicable
Registration Number
KCT0000151
Lead Sponsor
Hallym University Medical Center-Kangnam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

After obtaining the approval of institutional ethics committe and written informed consent, patients aged 18-60 yr of ASA physical status I or II scheduled to undergo elective monior surgery requiring general anesthesia.

Exclusion Criteria

Patients with a potentially difficult airway (Mallampati classification III or IV. Cervical spine disease, or a mouth opening of < 2.5 cm), signs of upper respiratory infection, history of reactive airway disease or gastro-esophageal reflux, and a history of allergic reaction to the anesthesia drugs (propofol).

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EC50 and EC95 of remifentanil for successful LMA insertion for men and women
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath